How The GOP Represents Another Country

Michele Bachmann

The Article: How Right-Wingers in Congress Came to Represent a Whole Different Country by Joshua Holland in AlterNet.

The Text: With an assist from some long-term demographic trends, House Republicans have redistricted, propagandized and policed themselves into another country.

As a result, they have become unmoored from the political incentives that typically drive law-makers’ decision-making process. Public opinion no longer sways them, and that is creating a potentially insurmountable problem for the party establishment’s efforts to broaden the GOP’s appeal beyond angry old white people.

House Republicans may care about the GOP’s national fortunes in the abstract, but too many are impervious to what the public at large wants because of the nature of the districts they represent. At the same time, a steady stream of spin from the conservative media provides insulation from the realities of American politics, and deep-pocketed outside groups punish Republicans for any deviation from right-wing orthodoxy.

Continue Reading

Email

An Epic Rap Battle Featuring Lenin, Stalin And Rasputin

Come at me, comrade.

Email

Winston Churchill’s Case Against Democracy

Churchill On Average Voter

I wonder how thick the intersection between “Average Voter” and “Average Jersey Shore Fan” is.

Email

Why Chemotherapy That Costs $70,000 In The U.S. Costs $2,500 in India

Chemo India

The Article: Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India by Thomas Bollyky in The Atlantic.

The Text: Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?

It’s seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.

Last week, India’s highest court rejected an application to patent Gleevec. While the legal issue in the case is important — the patentability of modifications to existing drugs under Indian law — the impact of the decision will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets.

Continue Reading

Email

The American Dream In 30 Seconds

Run faster, you lazy parasite!

Email

Hot On The Web